Clinical Trial Update: Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating desmopressin for nocturnal micturition frequency in Parkinson disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Parkinson Disease | Phase 4 | Status: TERMINATED